Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine- 123-BMIPP

Journal of Nuclear Medicine

Volumn 38, Issue 10, 1997, Pages 1503-1510

  Taki, Junichi ^a   Nakajima, Kenichi ^a   Matsunari, Ichiro ^a   Bunko, Hisashi ^a   Takata, Shigeo ^a   Kawasuji, Michio ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Fatty acid; Revascularization; Thallium 201

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; THALLIUM 201;

ADULT; AGED; ARTICLE; BLOOD POOL SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FEMALE; FUNCTIONAL ASSESSMENT; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; ECHOCARDIOGRAPHY; EXERCISE TEST; FATTY ACIDS; FEMALE; GATED BLOOD-POOL IMAGING; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030847819     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Opie LH. Metabolism of the heart in health and disease: part 1. Am Heart J 1968;76:685-698.
2. Opie LH. Metabolism of the heart in health and disease: part II. Am Heart J 1969;77:100-122.
3. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:685-698.
4. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981;23:321-336.
5. Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985;6:336-347.
6. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865.
7. 11C palmitic acid in ischemic and reperfused canine myocardium. J Am Coll Cardiol 1985;6:311-320.
8. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
9. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12(suppl):S39-S44.
10. Dudczak R, Schmoliner R, Angelberger P, Knapp FF, Goodman MM. Structurally modified fatty acids: clinical potential as tracers of metabolism. Eur J Nucl Med 1986;12(suppl):S45-S48.
11. Knapp FF Jr, Kropp J, Goodman MM, et al. The development of iodine-123-methyl-branched fatty acids and their applications in nuclear cardiology. Ann Nucl Med 1993;7(suppl II):SII-1-SII-14.
12. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
13. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
14. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
15. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-1285.
16. Taki J, Nakajima K, Matsunari I, et al. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischemic but viable myocardium: assessment with iodine-123-labeled beta-methyl-branched fatty acid. Eur J Nucl Med 1995;22:1385-1392.
17. Matsunari I, Fujino S, Taki J, et al. Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection. Am Heart J 1996;131:458-465.
18. Taki J, Nakajima K, Bunko H, Kawasuji M, Tonami N, Hisada K. Twenty-four-hour quantitative thallium imaging for predicting beneficial revascularization. Eur J Nucl Med 1994;21:1212-1217.
19. Righetii A, Crawford MH, O'Rourke RA, Schelbert H, Daily PD, Ross J Jr. Interventricular septal motion and left ventricular function after coronary bypass surgery: evaluation with echocardiography and radionuclide angiography. Am J Cardiol 1977;39:372-377.
20. Lindsay J Jr, Nolan NG, Kotlyarov EV, Goldstein SA, Bacos JM. Radionuclide evaluation of the interventricular septum after following coronary artery bypass surgery. Radiology 1982;142:489-493.
21. Schon HR, Schelbert HR, Najafi A, et al. Carbon-11-labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. II. Kinetics of Carbon-11 palmitic acid in acutely ischemic myocardium. Am Heart J 1982;103:548-561.
22. Schelbert HR, Henze E, Schon HR, et al. Carbon-11-labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. IV. In vivo demonstration of impaired fatty acid oxidation in acute myocardial ischemia. Am Heart J 1983;106:736-747.
23. Opie LH, Owen P, Riemersma RA. Relative rates of oxidation of glucose and free fatty acids by ischemic and nonischemic myocardium after coronary artery ligation in the dog. Eur J Clin Invest 1973;3:419-435.
24. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
25. 123I-15-(p-iodophenyl)-3-methyl pentadecanoic acid (BMIPP). Jpn J Nucl Med 1995;32:19-29.
26. Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974-1980.
27. Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985;6:336-346.
28. Nienaber CA, Brunken RC, Sherman CT, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18: 966-978.
29. Matsuzaki M, Gallagher KP, Kemper WS, White F, Ross J Jr. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation 1983;68:170-182.
30. Topol FJ, Weiss JL, Gunman PA, et al. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol 1984;4:1123-1134.
31. Carlson EB, Cowley MJ, Wolfgang TC, Vetrovec GW. Acute changes in global and regional rest left ventricular function after successful coronary angioplasty: comparative results in stable and unstable angina. J Am Coll Cardiol 1989;13:1262-1269.
32. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R. Reversal of chronic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:1193-1198.
33. Van Den Berg EK Jr, Popma JJ, Dehmer GJ, et al. Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation 1990;81;1210-1216.
34. Vanoverschelde JLJ, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-1523.
35. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
36. 123I branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7(suppl II):SII-41-SII-47.
37. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996;37:718-722.
38. Hashimoto A, Nakata T, Tsuchihashi K, Tanaka S, Fujimori K, Iimura O. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996;77:25-30.
39. Rocco TP, Dilsizian V, McKusick KA, Fischman AJ, Boucher CA, Strauss HW. Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 1990;66:158-163.
40. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-146.
41. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123 BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996;23:272-279.